Nestmedic S.A. (WSE:NST)

Market Cap	35.37M +104.4%
Revenue (ttm)	1.02M +5.1%
Net Income	-4.37M
EPS	n/a
Shares Out	55.43M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30
Open	0.6380
Previous Close	0.6280
Day's Range	0.6380 - 0.6380
52-Week Range	0.3900 - 1.0800
Beta	0.24
Analysts	n/a
Price Target	18.80 (+2,846.71%)
Earnings Date	Aug 12, 2026

About Nestmedic

Nestmedic S.A., together with its subsidiaries, manufactures, distributes, and sells telemedicine solutions under the Pregnabit brand. It offers Pregnabit and Pregnabit Pro medical devices operating in a telediagnostic model that support the work of doctors and midwives in measuring fetal heart rate and uterine contraction activity, as well as signaling fetal movements for monitoring fetal and maternal well-being in the final weeks of pregnancy. The company also provides Pregnabit Cloud, a software as a service system designed to work with tele...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2017
• Employees: 3
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NST

Financial Performance

In 2025, Nestmedic's revenue was 1.02 million, an increase of 5.06% compared to the previous year's 969,196. Losses were -4.37 million, -18.70% less than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 16, 2026

Data Sources Report a data error